05/27/2026
The energy carried through earlier today at ICGT in Paris, where our joint ALD / IDT / Cytiva workshop—Accelerating Personalized CRISPR Therapies—brought together strong engagement around what it takes to advance these programs from concept to clinic.
Great to see the collaboration across teams and hear how others in the field are tackling challenges around speed, control, and scalability in personalized approaches. Sessions like this continue to reinforce how important integrated expertise is as expectations for performance and precision evolve.
If you’re attending ICGT, there’s still time to connect onsite.